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Abstract
Background: Despite some advances in recent years, the genetic control of gonadal sex differentiation during
embryogenesis is still not completely understood. To identify new candidate genes involved in ovary and testis
development, RNA-seq was used to define the transcriptome of embryonic chicken gonads at the onset of sexual
differentiation (day 6.0/stage 29).
Results: RNA-seq revealed more than 1000 genes that were transcribed in a sex-biased manner at this early stage
of gonadal differentiation. Comparison with undifferentiated gonads revealed that sex biased expression was
derived primarily from autosomal rather than sex-linked genes. Gene ontology and pathway analysis indicated that
many of these genes encoded proteins involved in extracellular matrix function and cytoskeletal remodelling, as
well as tubulogenesis. Several of these genes are novel candidate regulators of gonadal sex differentiation, based
on sex-biased expression profiles that are altered following experimental sex reversal. We further characterised three
female-biased (ovarian) genes; calpain-5 (CAPN5), G-protein coupled receptor 56 (GPR56), and FGFR3 (fibroblast growth
factor receptor 3). Protein expression of these candidates in the developing ovaries suggests that they play an
important role in this tissue.
Conclusions: This study provides insight into the earliest steps of vertebrate gonad sex differentiation, and
identifies novel candidate genes for ovarian and testicular development.
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Background
Gonadal sex differentiation in vertebrate embryos in-
volves sexually dimorphic gene expression, leading to
ovarian or testicular development. While a number of
key gonadal differentiation genes have been identified
and validated in a variety of organisms, large gaps in our
understanding still exist [1, 2]. This likely underlies the
significant number of human Disorders of Sex Develop-
ment (DSD’s) that remain unexplained at the genetic
level [1]. Identification of novel regulators of embryonic
ovarian and testis differentiation is therefore required,
and will greatly improve our understanding of normal
and aberrant gonad sexual differentiation. The chicken
embryo provides a unique model system for studying
gonad development because development occurs in ovo
(in the egg), allowing gonadal development to be directly
manipulated [3]. In chickens and other birds, as in mam-
mals, sex is determined by sex chromosome inheritance.
However, birds have a ZZ male: ZW female sex chromo-
some system, which is the opposite of the XY male: XX
female system found in mammals. Genes located on the
sex chromosomes drive differentiation of the “bipoten-
tial” gonads into ovaries (in ZW females) or testes (in
ZZ males). Several key genes involved in mammalian
gonadal sex differentiation are conserved in chicken,
including male up-regulated DMRT1, SOX9 and AMH,
and female up-regulated Aromatase, FOXL2 and
WNT4/RSPO1 [2–12]. However, the Y-chromosome
linked SRY gene, which initiates testis development in
mammals, is absent in birds. The best candidate master sex
switch in birds is DMRT1, which is present on the Z sex
chromosome and is expressed more highly in male gonads
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compared to females prior to and during sexual differenti-
ation. Knockdown and over-expression of DMRT1 causes
feminisation and masculinisation of the gonads respectively
[3, 7]. Although a W-linked female (ovarian) determinant
may yet exist, our extensive analysis has so far not pro-
duced a convincing candidate gene [13, 14].
In chicken embryos, the gonads form on the medio-
ventral surface of the mesonephric kidneys at embryonic
day 3 (E3 - Hamburger and Hamilton stage 18) [15]. At
this stage, they are undifferentiated or “bipotential”. At
E6 (HH29), gonads begin morphological differentiation
into testes in ZZ embryos or unilateral ovary in ZW em-
bryos. Sex-specific gonadal morphology emerges at this
time, and a small number of genes showing sexually
dimorphic expression have been identified, notably the
ovarian determinants FOXL2 and aromatase in females
[11, 16, 17], and DMRT1, HEMOGEN and SOX9 in
males [1, 4, 8, 10, 18–21]. However, in chicken, the exact
functional relationships among these genes are unclear.
Furthermore, human DSD’s imply the existence of other
as yet unidentified gonad-determining genes in verte-
brates generally.
Previous screens in the mouse embryo have employed
various methods to isolate novel genes regulating go-
nadal sex differentiation, such as high throughput whole
mount in situ hybridization (WISH) [22], differential
display [23, 24], cDNA subtractive hybridization [25–28]
cDNA microarrays [19, 29, 30] and RNA-seq on sorted
germ cells [31]. However, technical limitations often
mean that these approaches assay only a small fraction
of the transcriptome, and some studies have sampled
stages when the gonads are larger but when differenti-
ation has already occurred. Nevertheless, several of these
large-scale studies have successfully identified hundreds
of genes with sexually dimorphic expression in embry-
onic mouse gonads. A microarray study on sorted go-
nadal somatic cells (using the Sf1-GFP reporter) from
10.5 and 11.5dpc found numerous sex-biased genes spe-
cific to the early differentiating Sertoli and granulosa
cells [32]. Another study used microarrays on gonadal
somatic cells to identify 2306 genes expressed in a sex-
specific manner prior to, during and after gonadal sex
differentiation (E10.5 – E13.5) [33]. An independent
microarray screen compared sorted supporting cells (Sry
or Sox9 – eGFP), interstitial or stromal cells (Mafb-eGFP)
and germ cells (Oct4-eGFP) from XY and XX mouse
gonads at E11.5, E12.5 and E13.5 [34]. These studies
as well as the others mentioned above identified novel
candidates such as Aard, Cst9, Mmd2, Cbln4, some of
which have been further characterised in gonad develop-
ment [24, 35–38]. Whilst these studies represent extensive
transcriptome profiling of embryonic gonads, deep RNA
sequencing (RNA-seq) is considerably more sensitive [39].
In addition, RNA-seq reveals expression for all mRNAs,
not only genes covered by microarray, allowing an
unbiased analysis.
In the current study, RNA-seq is used to assess sex-
biased gene expression at the onset gonadal sex differen-
tiation in embryonic chicken gonads. Our rationale is
based on the assumption that genes important for ovary
versus testis development will show sex-biased expres-
sion. We previously performed RNA sequencing on E4.5
gonads, at the bi-potential stage prior to sexual differenti-
ation [14]. By comparing gene expression from this early
stage to E6 (the onset of morphological differentiation),
we find novel genes and pathways that are activated sex-
specifically at the time of sexual differentiation; more than
1000 genes are transcribed in a sex-biased manner at this
stage, and the majority of these become biased between
E4.5 and E6. This is primarily due to an increased expres-
sion of autosomal, rather than sex-linked, genes between
these time points. Gene ontology and pathway analysis
indicate that these genes are involved in extracellular sig-
nalling as well as driving morphological changes such as
ECM, cytoskeletal remodelling and tubulogenesis. We also
find significant enrichment of genes reported in the em-
bryonic mouse gonadal screens in the genes identified in
our chicken screen, highlighting conservation of molecu-
lar mechanisms underlying gonad differentiation. Several
novel candidate gonadal sex differentiation genes are iden-
tified and validated in vivo. Three female-biased (ovarian)
genes are further characterised; calpain-5 (CAPN5), G-
protein coupled receptor 56 (GPR56), and FGFR3 (fibro-
blast growth factor receptor 3). These genes may play an
important role during ovarian development. This study
provides insight into the earliest steps of gonad sex differ-
entiation, and identifies novel candidate genes for ovarian
and testis development.
Results
Significant sex-biased gene expression in early
differentiating gonads (E6.0/stage 29)
To assess gene expression in the early differentiating
testes and ovaries, paired gonads from E6 (HH29) were
dissected and mRNA isolated as previously described
[14]. For each sex, 2 pools of 18 gonad pairs (from 18
individuals) were collected. Messenger RNA was then
processed and sequenced (Methods), resulting in an
average of 46 000 000 read pairs per sample. We have
previously performed the same analysis on E4.5 paired
gonads [14]. Expression for each gene and differential
expression (DE) analysis were then calculated (Methods).
Gene expression is calculated in Fragments Per Kilobase
of Exon Per Million Fragments Mapped (FPKM).
Significance is calculated using False Discovery Rate
(FDR) (see Methods).
RNA-seq analysis detected expression of 17108 genes.
As the gonads begin to differentiate at E6, a total of
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1003 genes showed significant DE between the sexes
(FDR <0.001). Of these, 347 were female-biased and 656
were male-biased (Fig. 1a). In contrast, at the earlier
time point of E4.5, when the gonads are morphologically
undifferentiated, only 267 genes were significantly DE
(193 male biased genes and 74 female biased genes;
FDR <0.001) (Fig. 1a, b). Thus, between E4.5 and E6 as the
gonads begin to differentiate, a four-fold increase in
sexually dimorphic transcript number was observed
(from 1.56 to 5.86 % of all expressed genes). Substantial
overlap was observed between the genes that were sexu-
ally DE at E4.5 and those at E6; 165 genes in males and 62
Fig. 1 Sexually dimorphic gene expression in the bi-potential and differentiating chicken embryonic gonads. a Venn diagrams indicating the
number of significantly DE (FDR <0.001) genes for each time-point (undifferentiated gonads E4.5, differentiating gonads E6). This is divided into
male-biased (blue) and female-biased (red). 193 genes were male biased at E4.5, and 656 at E6. Of these, 165 genes were DE at both time points,
with only 28 genes being DE at only E4.5. 74 genes were DE in a female biased manner at E4.5, and 347 at E6. 62 of these were DE at both time
points. b A heatmap of the top 400 DE genes for each sample (2 females and 2 males for each time point). The colour scale indicates the proportion
of counts in each sample with respect to the sum across samples, after normalising for library size. With red indicating the highest expression relative
to other samples and dark blue being the least. On the left is hierarchical clustering of these genes. The known W-linked genes are indicated by pink
lines while the Z-linked genes are indicated by blue lines. c The number of DE genes (both male and female biased) found on the autosomes (green
bars) versus the sex chromosomes (grey bars), for each time point
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in females (85.5 and 83.8 % of the E4.5 DE genes
were also DE at E6.5 in males and females respectively)
(Fig. 1a). Indeed, of the 267 DE genes at E4.5, only 40
(15 %) lost this bias at E6 (Fig. 1a) and the majority of
these (all but 5) reside on the sex chromosomes [W, Z or
suspected W chromosome (un-random)] [14]. This may
reflect changes in dosage compensation of these sex
chromosome genes or changes in the expression of W
linked genes [14, 40–42].
Hierarchical clustering was performed on the 400 most
significantly DE genes (those with the lowest P-values)
from E4.5 and E6 gonads. The clustering of genes on the
basis of expression level is represented in a heat map
(Fig. 1b). W-linked genes clustered together and showed
high differential expression in both female samples at both
time-points (Fig. 1b), consistent with our previous obser-
vations [14]. Similarly, Z-linked genes clustered together.
Importantly, autosomal genes that were DE were primarily
present in E6 and not E4.5 gonads, with female DE genes
clustering together for each sample and male DE genes
clustering. The overall number of DE sex-linked genes did
not greatly change between the time-points (E4.5 = 224,
E6 = 304). This indicates that the increase in biased genes
expression between E4.5 and E6 was largely due to tran-
scriptional changes in autosomal genes, which increased
from 43 DE genes at E4.5 (16 %) to 699 (70 %) at E6
(Fig. 1c). Taken together, these data show that between
E4.5 and E6, there was a significant increase in the
number of autosomal genes showing sexually dimorphic
expression. These genes are novel candidates for con-
tributing to gonad sexual differentiation.
Known sex-differentiation genes show dimorphic
expression
The expression profiles of known or putative regulators
of gonadal sexual differentiation were assessed at E4.5
and E6 (Table 1). Of the known sexual regulators based
on previous studies in chicken or mammals, only one
autosomal gene was significantly DE at E4.5 in females;
FOXL2 (FDR <0.001). At E6, FOXL2 continued to be dif-
ferentially expressed, and in addition CYP19A1/Aroma-
tase, HSD17B1 and NROB1 (DAX-1) transcripts became
female enriched (Table 1). Four genes showed significantly
male-biased expression at both time-points; HSD17B4,
DMRT1, HEMOGEN, and AMH (FDR <0.001). Inhibin A
and B trended towards sexual dimorphism (FDR 0.0027,
0.0012 respectively) at E4.5, and by E6 both were signifi-
cantly male-enriched (Table 1). SOX9 showed male-biased
expression at E6 only, confirming previous studies sug-
gesting that it lies downstream of Z-linked genes DMRT1
and HEMOGEN [3, 20]. These data imply that major
components of the sex determination pathways are
activated between E4.5 and E6 (developmental stages
HH 25/26 to HH 29/30). Several other sex-development
genes show gonadal expression but no sexual dimorphism
(Table 1). Indeed, many known regulators of bipotential
gonad formation such as LHX9, EMX2, GATA4 and
FOG2 were very highly expressed in both female and male
E4.5 gonads, while expression decreased significantly in
E6 gonads (Table 1). This confirms that the E4.5 gonads
are still undifferentiated, whereas at E6 the differentiation
process has commenced, reflected by down-regulation of
genes required for the formation of the undifferentiated
gonad and up-regulation of sex-differentiation genes.
While no RNA-seq analysis has yet been reported for
whole embryonic mouse gonads, large-scale transcrip-
tional screens have been carried out [22]. To assess con-
servation of sexually dimorphic genes in other organisms,
chicken DE genes at E6 (P-value <0.05) were compared
with those from three separate large-scale mouse micro-
array screens [32, 33, 43]. The first of these studies assayed
somatic cells from XX and XY embryonic mouse gonads
at E10.5, E11.5, E12.5 and E13.5, with E11.5 – 12.5 being
equivalent to chicken E6 (stage 29/30) [33]. The second
study used isolated somatic cells from XX and XY gonads
at 10.5 and 11.5dpc and identified genes showing male
up-regulation or down-regulation specific to 11.5dpc, as
well as female up-regulation at 11.5dpc [32]. In the third
study, isolated supporting cells, stromal/interstitials cells
and germ cells were profiled from XX and XY mice [34].
All three of these studies used different methods of asses-
sing differential expression, but all used a P-value of 0.05
to assess DE genes at each time point. To compare our
data to these studies, we used a P-value of 0.05 to find E6
DE genes in the chicken. This results in a list of 2123
genes. This gene list was then compared with those identi-
fied as sex-biased at 11.5 and 12.5dpc from Nef et al. [33]
and Jameson et al. [34], and with those identified in
the other study [32]. Fisher’s exact tests were also
carried out to test for statistically significant enrich-
ment of each data set in our set. When we compared
each data set to our DE gene list we found significant
enrichment (P-value <0.001) for each study (Table 2).
Our RNA-seq study was carried out on whole gonads,
and will hence encompass expression from various
populations of cells include supporting cells and germ
cells. By comparing to each cell lineage from the
Jameson et al. study, we could also see that DE genes
associated with supporting cell (443), and interstitial cells
(210) are represented in our data set at a significant level
(Table 2 P-value <0.001). Germ cells were enriched with a
P-value of 0.00123 (163 genes). Overall, we found 76
genes in common between the three mouse studies
alones (specifically in the supporting cell populations)
(Table 2). Of these, 20 genes were also DE in our
study (Table 2). Thus significant overlap between dif-
ferentiating mouse and chickens gonads was observed,
suggesting that similar genetic pathways are engaged
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between mammals and avians, validating the use of
chicken embryonic gonads to screen for novel sex
determination candidates.
20 genes were common between all studies of somatic
cells and our study (Table 2). These genes were Col14a1,
Cyp11a1, Ogt, Slc20a1, Lect1, Nedd9, Prss12, Fst, Hpse,
Gpm6b, Tesc, Atp1a1, Dapk1, Adm, Scarb2, Mef2c,
Tyro3, Gdnf, Bace2 and Nac1. Some of these genes have
been implicated in sex development previously. CYP11A1
mutations cause congenital adrenal insufficiency and with
partial or complete 46,XY sex reversal in humans. GDNF
or glial cell line derived neurotrophic factor exerts a
proliferative effect on developing mouse Sertoli cells
[44]. Finally, Tescalin (Tesc) has been previously de-
scribed as an early testis gene [45, 46], although no
gonadal phenotypes have been described in a null
mutant mouse [47]. We also analysed the overlap be-
tween these studies and our dataset using a P-value
cut off of 0.001 to determine DE genes. This dataset
has 1003 genes, half of what we have using the less
stringent P-value of 0.05. Consistently, we found re-
duced numbers of overlapping genes, but enrichment
was still significant between all groups (Additional
file 1: Table S3).
Table 1 Expression of known and putative sex genes in embryonic chicken gonads, revealed by RNA-seq
Gene name Gene ID E4.5 gonads E6 gonads
Female Male P-Value Fem:Male FC Female Male P-Value Fem:Male FC
CYP19A1 ENSGALG00000013294 0.041 0.004 0.115 7.905 122.663 0.061 0.000 1977.060
FOXL2 ENSGALG00000021009 5.954 0.931 0.000 6.178 43.945 0.996 0.000 44.013
HSD17B1 ENSGALG00000027429 6.805 3.736 0.010 1.756 111.132 15.557 0.000 7.106
SOX10 ENSGALG00000012290 4.548 2.636 0.032 1.789 3.563 1.476 0.000 2.170
NR0B1 ENSGALG00000016287 14.337 12.882 0.743 1.157 39.036 16.230 0.000 2.126
BMP2 ENSGALG00000008830 6.477 4.325 0.314 1.443 12.433 6.028 0.000 2.066
DMRT2 ENSGALG00000026790 0.062 0.083 0.880 0.722 0.117 0.058 0.498 1.998
CBLN4 ENSGALG00000007772 0.737 0.534 0.764 1.311 0.307 0.156 0.189 1.997
FGF9 ENSGALG00000025748 1.911 1.673 0.901 1.097 1.686 1.129 0.074 1.498
RSPO1 ENSGALG00000001946 1.063 0.970 1.000 1.048 0.462 0.324 0.453 1.429
CBX2 ENSGALG00000023338 9.871 10.314 0.870 0.917 6.147 6.185 1.000 0.998
CTNNB1 ENSGALG00000011905 425.969 449.949 0.979 0.977 273.702 246.522 0.977 0.983
LHX9 ENSGALG00000002223 105.310 104.413 0.962 1.038 79.966 76.430 0.680 0.921
EMX2 ENSGALG00000009302 122.967 117.497 0.886 1.090 77.461 75.557 0.742 0.904
NR5A1 ENSGALG00000001080 38.599 50.040 0.129 0.745 52.266 60.456 0.444 0.863
MAP3K4 ENSGALG00000020003 8.796 9.495 0.709 0.885 7.635 9.513 0.133 0.803
ZFPM2/FOG2 ENSGALG00000016078 45.987 47.630 1.923 1.016 0.581 0.788 0.024 0.798
MAP3K1 ENSGALG00000014718 34.143 48.070 0.276 0.671 25.100 33.224 0.323 0.756
WNT4 ENSGALG00000004790 26.562 29.000 0.979 0.956 14.432 17.492 0.104 0.728
GATA4 ENSGALG00000022821 2060.253 2782.683 1.367 0.770 531.061 519.498 0.269 0.726
SOX8 ENSGALG00000005263 1.240 1.502 0.791 0.851 1.207 1.625 0.126 0.655
DMRT3 ENSGALG00000010161 0.905 1.440 0.290 0.647 0.927 1.482 0.022 0.551
HSD17B4 ENSGALG00000002187 23.172 45.287 0.000 0.530 22.422 40.765 0.000 0.488
INHBB ENSGALG00000028770 5.751 10.439 0.001 0.532 19.171 41.431 0.000 0.462
DMRT1 ENSGALG00000010160 80.634 152.988 0.000 0.548 87.845 207.079 0.000 0.373
INHA ENSGALG00000011234 1.698 3.300 0.003 0.497 4.081 24.239 0.000 0.168
HEMGN ENSGALG00000023061 4.119 10.467 0.000 0.380 16.499 112.377 0.000 0.146
SOX9 ENSGALG00000004386 1.608 2.130 0.635 0.785 1.073 10.613 0.000 0.090
AMH ENSGALG00000024368 7.965 25.730 0.000 0.322 56.914 1878.929 0.000 0.027
The expression of known or implicated sex genes in the female and male gonads, at E4.5 and E6. Expression is measured in FPKM (fragments per kilobase of exon
per million fragments mapped). P-values (FDR) indicate whether the difference between females and males is significant, and Fem:Male fold-change (FC) is the
difference between females sample expression and male samples expression. Genes are ranked in terms of their FC at E6. Those in bold are significantly different
(P-value (FDR) <0.001) between sexes at E6
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Transcriptional changes in the differentiating gonads
reflect morphological differentiation
To elucidate novel pathways engaged during sexual dif-
ferentiation of ovaries and testes, pathway analysis was
performed on the dataset. To this end, genes were filtered
that were only sexually dimorphic at E6 (FDR <0.001), but
not in the undifferentiated gonads (E4.5). Genes previ-
ously implicated in sex determination or differentiation
were removed, to reveal novel activated pathways. Gene
ontology (GO) analysis was carried out on this list of
774 genes (Additional file 2: Table S1) using DAVID
[48, 49]. We assessed three ontological categories: Bio-
logical process (BP), Cellular component (CC) and Molecu-
lar function (MF) (Table 3). The top 3 BP categories in DE
genes were tube development, cell proliferation and respira-
tory tube development. The CCs most represented were
extracellular and cell surface. The MFs were lipid binding,
growth factor activity and ATPase activity (Table 3).
To assess the probable functions of the genes in this
data set, we used DAVID functional analysis of KEGG
pathways [48]. The top five KEGG pathways that were
significantly engaged (based on calculated P-value <0.05)
Table 3 Gene ontology and KEGG pathway analysis of gonad differentiation candidates
Gene ontology category Gene count % P-value
Biological process
Tube development 19 2.7 1.90E-06
Regulation of cell proliferation 30 4.3 1.40E-06
Respiratory tube development 12 1.7 2.20E-05
Cellular component
Extracellular region 50 7.2 1.20E-05
Cell surface 14 2 9.40E-04
Extracellular region part 28 4 1.60E-03
Molecular Function
Lipid binding 15 2.1 2.70E-03
Growth factor activity 11 1.6 3.90E-03
ATPase activity 7 1 4.10E-03
KEGG pathway Term Gene count % P-value
Focal adhesion 21 3 2.90E-04
Dorso-ventral axis formation 5 0.7 1.30E-02
Regulation of actin cytoskeleton 16 2.3 2.20E-02
ECM-receptor interaction 9 1.3 2.60E-02
Cytokine-cytokine receptor interaction 13 1.9 5.00E-02
Genes showing DE expression at E6 but not at E4.5 were analysed for gene ontology and KEGG pathway enrichment using DAVID software [48, 49]. The top 3
gene ontology categories for biological process, cellular component and molecular function are shown, along with the gene count, percentage of total genes
input and the P-value. The top 5 KEGG pathways are shown for the same data set
Table 2 Genes found in additional mouse gonadal screens
Study Chicken E6 DE genes in common P-value for enrichment
[1] Beverdam and Koopman, [32] 89 1.32E-10
[2] Nef et al. [33] 46 4.70E-05
[3] Jameson et al. [34], Supporting cells 443 2.54E-19
[4] Jameson et al. [34], Stromal/interstitial cells 210 5.48E-18
[5] Jameson et al. [34], Germ cells 163 1.23E-03
Common between [1], [2], [3] 76 N/A
Common between [1], [2], [3] and chicken E6 20 N/A
Col14a1, Cyp11a1, Ogt, Slc20a1, Lect1, Nedd9, Prss12, Fst, Hpse, Gpm6b,
Tesc, Atp1a1, Dapk1, Adm, Scarb2, Mef2c, Tyro3, Gdnf, Bace2, Nac1
Comparison of chicken genes showing significant DE at E6 (P-value < 0.05) and three mouse microarray screens Beverdam et al. [32], Nef et al. [33] and Jameson
et al. who assayed supporting cells, germ cells and interstitial/stromal cells [34]. 20 genes were common between our study and the three mouse supporting cell
gene sets. These are listed
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were focal adhesion, dorsal-ventral axis formation, regu-
lation of actin cytoskeleton, ECM-receptor interaction,
and cytokine-cytokine receptor interaction (Table 3).
Numerous DE genes were implicated in each of these
pathways (i.e. Additional file 3: Figure S1A, B). The high
number of genes involved in extracellular function and
in the engagement of pathways involved in actin cyto-
skeletal remodelling and ECM function is consistent
with the significant morphological changes that are
taking place as the gonads differentiate into ovaries or
testis. Indeed, the embryonic ovary and testis differ sig-
nificantly in their morphology; the ovary develops a
thickened cortex to house germ cells, while the medulla
becomes fragmented, and the testis organizes into base-
ment membrane bound seminiferous cords that enclose
germ cells and supporting Sertoli cells. These morpho-
logical events begin at E6. Vasculature and seminiferous
cord development are important in the testis [43], which
was reflected here in the number of genes implicated in
tube formation and development. Panther pathway ana-
lysis also revealed that the TGF-β pathway was signifi-
cantly represented (P-value = 0.05), including BMP2, 3, 4
and 7 and BMPR2 as well as JUN and Myostatin. Indeed,
BMP signalling has been implicated in ovarian and fol-
licle development [50–53], although the exact role of
these BMPs at this early stage needs to be elucidated.
Novel candidates for testis and ovarian development
Known sex determination genes were effectively identi-
fied from the RNA-seq data set, many of which had
sexually dimorphic expression only at E6. Based on this
analysis, the sequencing data was interrogated to identify
novel genes involved in chicken gonadal sex differenti-
ation. For potential testis-determining genes, the data
was filtered for genes showing sexually dimorphic ex-
pression at E6 (FDR < 0.001) which were male biased
(Log2 fold change/Fem:male ratio of less than 1) and
with a male gonadal expression of more than 10 FPKM.
FPKM of 10 was chosen as a cut-off based on the ex-
pression of known gonad genes and on previous studies
in our lab that suggest in vivo methods such as WISH
do not detect the expression of genes with less than this
value (data not shown). These testis genes were ranked
according to P-value and the top 45 genes were tabu-
lated (Additional file 4: Table S2). This list includes
previously mentioned known sex-regulators such as
DMRT1, HEMOGEN, AMH and SOX9. From this list,
four candidate genes were chosen for further study,
based on gene ontology and expression. Specifically
we chose genes with a variety of expression levels/
fold changes, and which are thought to be involved in
transcriptional regulation or morphogenesis/cell differen-
tiation. These were laminin1 (LAMA1), BMP receptor 2
(BMPR2), zinc-finger 385B (ZNF385b) and a novel,
uncharacterised gene on the Z chromosome that we
designated NZP (Table 4). To identify genes involved in
ovarian development, genes were filtered for significant
sexual dimorphism at E6 (FDR <0.001), female bias (Log2
fold change > than 1) and with a female expression greater
than FPKM 10. All W-linked genes were removed as these
have been analyzed previously [14], and the remaining
genes were ranked according to P-value (Additional file 4:
Table S2), and the top 45 taken. From this list, three novel
candidate genes for ovarian development were chosen
based on their expression profiles and on their gene ontol-
ogy. These were calpain-5 (CAPN5), G-protein coupled
receptor 56 (GPR56) and fibroblast growth factor receptor
3 (FGFR3) (Table 4).
Whole-mount in situ hybridisation (WISH) of chicken
embryonic urogenital systems (UGS) at E6 was used to
confirm mRNA expression of the seven candidate genes
(Figs. 2 and 3). By this method, genes could be assessed
for their degree of gonad specificity, and their expression
could be localised to a gonadal cell type. WISH con-
firmed male-biased expression in the E6 gonads for all
four of the testis candidate genes; LAMA1, BMPR2,
ZNF385B, and NZP (Fig. 2a-d versus i-l). Over-staining
and sectioning showed that all four of these genes were
expressed in the seminiferous cords of the developing
testis (Fig. 2e-h). BMPR2, ZNF385b and NZP had only
low level, diffuse expression in the ovary (Fig. 2i-o), while
LAMA1 had expression in the juxta-cortical medulla of
Table 4 RNA-seq expression of novel candidates for in vivo validation
Gene
name
Gene ID Position E4.5 gonads E6 gonads
Female Male P-Value Fem:Male FC Female Male P-Value Fem:Male FC
GPR56 ENSGALG00000001085 chr11:529482-535232 7.796 5.909 0.328 1.277 58.422 6.309 0.000 9.258
FGFR3 ENSGALG00000015708 chr4:82973160-83026374 7.806 6.302 0.659 1.184 14.262 2.479 0.000 5.770
CAPN5 ENSGALG00000000750 chr1:192455766-192506610 13.372 14.865 0.852 0.924 36.491 8.763 0.000 3.690
BMPR-II ENSGALG00000008459 chr7:11320598-11416297 16.131 26.090 0.396 0.578 9.868 37.448 0.000 0.264
ZNF385B ENSGALG00000009012 chr7:14343681-14477554 20.765 31.951 0.000 0.624 25.092 74.033 0.000 0.338
LAMA1 ENSGALG00000014615 chr2:99400292-99499147 20.282 24.625 0.337 0.783 10.520 30.161 0.000 0.349
NZP ENSGALG00000021163 chrZ:42249103-42257660 12.561 34.068 0.000 0.383 22.707 113.353 0.000 0.175
Expression (FPKM) is shown for female and males gonads at E4.5 and E6, with P-values (FDR) for the sex differences (DE) and the fold change between sexes
Ayers et al. BMC Genomics  (2015) 16:704 Page 7 of 19
the ovary (Fig. 2l, p). None of these genes were notably
expressed at other sites within the urogenital system.
All three candidate ovarian genes showed strong
female-biased expression at E6.0 (stage 29/30) (Fig. 3a-c
versus g-i) in WISH. CAPN5 and GPR56 were strongly
expressed in female gonads but only weakly expressed in
males (Fig. 3a, b and g, h). GPR56 and FGFR3 had no
expression in other sites within the urogenital system,
while CAPN5 showed expression in the adrenal glands
of both males and females (Fig. 3a, g arrows). Sectioning
Fig. 2 Male candidate gene expression in vivo. Whole mount in situ hybridisation for 4 male-biased candidate genes, on E6 UGS (UGS) from males
and females. BMPR2 is more highly expressed in males (a, e) than in females (i, m). In over-stained sections, BMPR2 appears to be expressed in
the testis cords (e). ZNF385b shows greater expression in males (b, f) than females (j, n), consistent with RNA-seq. In males it is expressed in the
cords (f). NZP, a novel Z-protein, is expressed in males more highly than females (c, g versus k, o). It is also expressed in the cords of males (g).
LAMA1 is also higher in males (d) than females (l) and is expressed in testis cords in males (h), with some weak expression in the juxta-cortical
medulla in females (p). These results are consistent with RNA-seq data. Typically, 3 UGS from each sex were used for each probe, and these
images are representative. A sense control probe did not show any staining for any of the candidate genes (data not shown)
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revealed that CAPN5 was expressed in a subset of
medullary cells close to the cortex – the juxta-cortical
medulla (Fig. 3d). GPR56 and FGFR3 were expressed
primarily in the cortex of the ovary (Fig. 3e, f ). Taken
together these results indicate that the gonad RNA-seq
data was robustly validated by in situ hybridisation.
Novel sex-differentiation candidates show altered
expression following experimental sex-reversal of gonads
RNA-seq and WISH analysis revealed the expression of
three female- and four male-biased gonadal genes. To
test the involvement of these genes in the gonadal differ-
entiation pathways, experimental sex reversal was carried
out using the aromatase inhibitor, fadrozole. Fadrozole
inhibits the activity of the aromatase enzyme, blocking
oestrogen production, and resulting in female to male sex
reversal of the embryonic gonads [54, 55]. Fadrozole was
injected into fertile eggs at E3 (stage 19) and gonads were
harvested from embryos at E9 (stage 33). WISH was used
to compare gene expression to that of stage-matched
controls.
The male-biased genes, BMPR2 and ZNF385b (Fig. 4a-c
and d-f ) were up-regulated in sex-reversed females
(Fig. 4c, f) compared to control females (Fig. 4b, e), suggest-
ing that the expression of these is a consequence of male
sex differentiation. While NZP also showed up-regulation
Fig. 3 Female candidate genes expression in vivo. Whole mount in situ hybridisation for 3 female-biased candidate genes, on E6 UGS from males
and females. CAPN5 is more highly expressed in female (a) than in males, where only low staining is observed (g, j). CAPN5 is also expressed in
the adrenal glands in both females and males (a, g arrows). In over-stained sections CAPN5 appears to be expressed in the juxta-cortical medulla
of the ovary (d). GPR56 shows strong expression in female gonads (b) and no expression in the males (h, k), consistent with RNA-seq. In females
it is expressed in the cortex of the ovary, with a lower level in the medulla (e). FGFR3 is also higher in females (c) than males, which show low
expression (i – gonads delineated by lines). FGFR3 is mostly expressed in the ovarian cortex (f), and in the male weakly in a subset of cord cells
(l, arrow heads). These results are consistent with RNA-seq data. Typically, 3 UGS from each sex were used for each probe, and these images are
representative of what is seen. A sense control probe is also tested, and did not show any staining for any of the genes (data not shown)
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Fig. 4 (See legend on next page.)
Ayers et al. BMC Genomics  (2015) 16:704 Page 10 of 19
in the treated female (Fig. 4i), expression of this gene
is low at this time-point in both sexes (Fig. 4g, h).
Similarly, LAMA1 expression was weaker in the male
at this time point, and only a weak activation was ob-
served in the female treated with fadrozole (Fig. 4j-l).
Further functional analysis of these three candidate
testis genes is currently underway. Antibodies have
been raised against ZNF385b and knockdown is being
conducted using our established virally delivered RNAi ap-
proach [7]. The female-biased genes CAPN5 (Fig. 4m-o),
GPR56 (Fig. 4p-r) and FGFR3 (Fig. 4s-u) all showed
down-regulation in fadrozole treated female gonads
(Fig. 4o, r, u) compared to the untreated female. In
GPR56, only the left gonad of females showed robust
expression at this point (Fig. 4q). This was lost in
fadrozole treated gonads (Fig. 4r). These data show
that these genes are expressed in female-specific cell
types as a consequence of the early steps of ovarian
differentiation. Their expression is subsequently lost
when ovaries are sex reversed. These data indicate that
the RNA-seq screen was used to successfully identify
candidate genes for ovarian or testis development. As
our interest lies in identifying novel genes involved in
ovary differentiation, we further focused on CAPN5,
GPR56 and FGFR3.
Candidate ovarian genes are translated during gonad
development
Only a small number of genes have so far been shown to
play a deterministic role in ovarian differentiation and
development [1]. Screens such as the one described here
provide additional candidate genes, which will fill gaps
in our understanding of ovarian morphogenesis. There-
fore we focused on the female-biased candidates FGFR3,
CAPN5 and GPR56. FGFR3 is a receptor for fibroblast
growth factors (FGFs) which have been shown to play a
central role in gonad differentiation and germ cell devel-
opment [56–58]. A role for FGFR3 has not been de-
scribed in the ovary during embryogenesis. Calpain-5
(CAPN5) encodes an intracellular calcium-dependent
cysteine protease, and has similarity to the Caenorhabditis
elegans sex determination gene tra-3. CAPN5 has not been
implicated in gonad development in vertebrates. GPR56 is
an adhesion-associated G-protein coupled receptor that
mediates intracellular signal transduction. GPR56 null mice
have impaired testis formation and infertility [59]. No
phenotype has been reported in female mice.
To study these proteins, a commercial antibody was
used for FGFR3 and in-house antibodies were raised
against CAPN5 and GPR56 proteins. These new anti-
bodies were tested for specificity (Additional file 5:
Figure S2). To this end, open reading frames of chicken
CAPN5 and GPR56 were cloned and expressed them in a
chicken fibroblastic cell line (Additional file 5: Figure S2).
Two polyclonal antibodies were tested for each protein, at
various concentrations (data not shown). For GPR56,
while low background staining was observed in untrans-
fected DF1 cells (Additional file 5: Figure S2A), strong ex-
pression was observed when transfection with the GPR56
plasmid was carried out (Additional file 5: Figure S2B).
This staining appeared to be cytoplasmic, excluded from
the nucleus (Additional file 5: Figure S2Bi, Bii). CAPN5
specific staining is observed only in the transfected
cells and not in the control cells (Additional file 5:
Figure S2C, D), and it appears punctate throughout the
cytoplasm (Di, Dii). These antibodies were then used to
assay expression in embryonic gonads. CAPN5 was
detected in female gonads at E6 in a subset of cells
in the medulla. By E8.5 (HH stage 32) this expression
had increased and was evident in a subset of juxta-
cortical medullary cells (Fig. 5b). CAPN5 appeared to
be cytoplasmic in these cells (Fig. 5c). This protein
expression pattern was consistent with the mRNA
expression pattern. Some low level punctate staining
was observed in the males from E8.5 (Fig. 5a). GPR56
was also expressed from E6.5 (HH 30) in the female,
with only background staining in the male. Expression
of GPR56 was highest in the cortex of the ovary where it
appeared to be cytoplasmic and at the plasma membrane
(Fig. 5e, f ). (See also Additional file 5: Figure S2E, F for
additional images.) The FGFR3 antibody detected protein
in the germ cells in both sexes (Fig. 5g, h), where it is cyto-
plasmic or at the plasma membrane (Fig. 5Gi). Staining
was stronger in the ovary (Fig. 5h), especially in the cortex
(Fig. 5i), which may reflect its expression in somatic
cortical cells as well as germ cells.
The female-biased expression of these proteins, espe-
cially CAPN5 and GPR56, indicates that they might play
(See figure on previous page.)
Fig. 4 Expression of candidate genes is altered in sex-reversed gonads. Whole mount in situ of E9 UGS from male controls, female controls or
fadrozole treated females. The expression of male candidate genes BMPR2 (a-c) and ZNF385b (d-f) changed dramatically in fadrozole treated
embryos (c, f), where expression was almost at the same level as untreated males (a, d). NZP also had increased expression in treated females
(i) compared to untreated (h), although expression of this gene has generally dropped in control males at this stage (g). LAMA1 expression
had also dropped in males at E9 (j), and only low expression was found in females (k). A slight increase in expression was seen in treated
females (l). CAPN5 was lost from the gonads (dotted lines) but not the adrenal gland of treated females (o) compared to control females (n) .
In the gonads it obtained a similar level of expression to control males (m). GPR56, which is absent in males (p), was also lost from treated fe-
males (r) whereas in untreated females it is strongly expressed in the left ovary (q). Similarly, fadrozole treatment abolished FGFR3 staining in the
gonads (u), to a similar level as untreated males (s) from normal strong expression in females (t)
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a role in ovarian development from the time of sexual
differentiation, and further validates RNA-seq as a useful
tool for the identification of novel candidate gonad dif-
ferentiation genes. Further studies including functional
analysis are currently underway in our laboratory to
assess the precise role of these genes.
Discussion
Sexual differentiation of the gonads during embryonic
development involves the sex-biased expression and ac-
tion of several well-characterised regulators of ovarian
or testicular development. However, only a small num-
ber of genes have been identified and many cases of
unexplained human DSDs point to the existence of
uncharacterised genetic regulators of embryonic gonadal
development. RNA-seq was employed here to identify
novel candidate sex genes, using embryonic chicken
gonads as a model system. This study is the first to
report RNA-seq in entire gonads at the time of sexual
differentiation in a vertebrate species. We have com-
bined previous analysis of female and male gonads at
E4.5, prior to sexual differentiation, with new data
from E6 gonads. By comparing these two time-points,
a detailed view of the gonad transcriptome during
sexual differentiation has been revealed.
While the expression of several known or putative
gonad sex determinants has previously been assessed in
embryonic chicken gonads [10, 16, 19, 60–63], this has
often been based on assessment of suspected genes and
pathways, employing whole mount in situ, qRT-PCR, or
protein expression. These screens have been successful
in identifying candidates, some of which are also found
here (e.g., CLDN11, INHA, InhibinA and B and BMPR2).
[64]. In addition, some of these studies have identified
transcriptional differences between the left and right
ovary, the latter of which regresses in chicken [64, 65]. We
Fig. 5 Novel candidate female genes are translated in the embryonic gonads. Immunofluorescence staining using antibodies raised in house
(CAPN5 and GPR56) or commercial antibodies (FGFR3) in E8 gonads. CAPN5 protein is only weakly expressed in males (a), but shows high expression in a
subset of cells in the female gonads (b). These cells are present in the juxta-cortical medulla, and staining appears cytoplasmic (c). GPR56 is expressed in
the cortex of the female (e, f), where it appears cytoplasmic, although this staining is weak, and GPR56 is weak in male gonads (d). FGFR3 is expressed in
the male gonads (g) and in the female gonads (h), where it is strongly expressed in the membrane or cytosol of the germ cells (see insert Gi). Strong
staining in the female cortex (i) is probably due to germ cell expression, although may also be due to additional cortical cells expressing this receptor
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did not separate left and right ovary in this study.
Nevertheless, these approaches are biased towards
known pathways inferred from other vertebrates. They
lack both the sensitivity and detail of RNA-seq. Indeed,
RNA-seq can reveal early changes in gene expression
undetectable by other methods.
Firstly, the RNA-seq data has provided information on
the expression of known or putative sex genes. These
results are interesting when considering the inferred
molecular hierarchy of genes and their signalling in the
gonads, both in chicken and other species. For example,
in females FOXL2 shows sexual dimorphism from E4.5,
preceding that of aromatase, which does not become
significantly DE until E6. This is consistent with previous
studies that have suggested that FOXL2 acts upstream
of other female genes, at least at the transcriptional
level [11, 16, 66]. Indeed, in other species ranging from
fishes to mammals, FOXL2 is a putative or known ac-
tivator of aromatase gene expression [67, 68]. Given
that Aromatase expression and oestrogen synthesis is
essential for ovary formation in birds, FOXL2 likely
occupies a key position in the female pathway. In
addition, a recent study has suggested that the main
role of FOXL2 is as a repressor of male genes [69],
and this may explain the importance of early FOXL2
expression where it would drive the gonadal primordium
towards an ovarian fate by repressing male genes and
activating female genes.
In the avian embryo, and indeed other vertebrates, the
activator of FOXL2 has not been clearly defined, and
while a W-chromosome linked gene may fulfil this role
in the chicken, no convincing candidate exists. Alterna-
tively, FOXL2 may be activated by a factor common to
both sexes that is antagonized by elevated expression of
Z-linked DMRT1. DMRT1 can antagonise FOXL2 expres-
sion, as evidenced in DMRT1 knockdown gonads, which
exhibit elevated FOXL2 transcription and feminization [7].
Both Z-linked DMRT1 and HEMOGEN show significant
male-bias at E4.5, as does AMH, preceding SOX9,
which becomes male up-regulated at E6. This indicates
that DMRT1/Hemogen activate SOX9 transcription,
which is supported by recent over-expression studies
in ovo [3, 10, 20].
As the gonads enter the phase of sexual differentiation,
they up-regulate sexually dimorphic gene expression,
most of which is autosomal. Given that some known sex
determining genes are dimorphic prior to this activation
(e.g., DMRT1 and FOXL2), these activated genes at E6
(stage 29/30) are likely downstream regulators of ovarian
versus testis development. Gene ontology and KEGG
pathway analysis suggests that many of these genes are
involved in the restructuring of the gonad into the
morphologically distinct testis or ovary. There was an
over-representation of genes involved in ECM and
cytoskeleton formation and regulation in the datasets.
Indeed, a study that used network approaches to analyse
sex-biased gene expression in chickens suggested that
genes of the same sex bias tended to be more connected
to each other than expected, and that when genes were
grouped into sex-biased modules these showed func-
tional homogeneity [70].
Our RNA-seq was carried out on whole chicken go-
nads and therefore encompasses expression from both
supporting cell types (presumptive granulosa and Sertoli)
as well as from interstitial cells and from germ cells. To
assess the relative importance of each cell type and the
potential overlap with mouse gonadal expression profiles
we compared our screen and three high throughput
microarray screens carried out on embryonic mouse
gonads/cells at a similar stage of differentiation [32–34].
We found significant enrichment (P-value <0.001) be-
tween the genes identified in each study and our own. In
addition, these analyses indicate that we have found DE
genes from not just supporting cell types, but also from
the germ cell and stromal/interstitial cell pools, albeit to
a lesser extent. Interestingly, we found only 76 genes
were common between the three mouse studies (specif-
ically in the supporting cells only). This probably reflects
the subtle differences between each of these screens
such as the transgenic mice used, the sorting methods,
the microarray platforms and the analyses. Interestingly
though, of these 76 genes 20 were also DE in our data
set. The presence of several already characterised gonadal
genes in this list means that these represent excellent
candidates for further investigation.
The RNA-seq analysis also provided novel candidate
genes for sexual differentiation in female and male
chicken embryos. By comparing expression in females and
males at E6 numerous significantly sexually dimorphic
genes not previously implicated in gonad development
were identified. To validate these lists, several male and fe-
male biased genes of interest were chosen, based on their
gene ontology and expression. These were validated in
vivo using WISH to assess their expression in the UGS
and in sex reversed gonads. For all genes assayed, expres-
sion profiles in WISH mimicked those in the RNA-seq
data, which we have also found previously with W genes
[14]. For male-biased genes, expression was present in the
testis cords, and was up-regulated when female gonads
were experimentally sex-reversed using the aromatase in-
hibitor fadrozole. The female genes assayed were either
present in the medulla (CAPN5) or the cortex (FGFR3
and GPR56) of the developing ovary. In the presence of
fadrozole, these female-biased genes had reduced expres-
sion, which was similar to the level observed in ZZ
males. These results suggest that RNA-seq has suc-
cessfully identified candidate genes for gonadal sexual
differentiation in the avian system.
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Only a small number of genes implicated in ovarian
development have been described. Many of these have
derived from analysis of human or animal disorders of
sex development, i.e. WNT4 [71], R-spondin1 [72, 73],
FOXL2 [74] reviewed in [1]. There are still gaps in our
understanding of both the initial triggers and the down-
stream modulators of ovarian development. This study
has identified numerous female-biased genes, which may
play a role in ovarian differentiation. Indeed, we focused
our studies on three of these genes, using specific anti-
bodies against the chicken proteins. Protein expression
was similar to that revealed by the RNA-seq and WISH
analyses. Closer investigation into expression provided
insight into the potential role of these genes.
One candidate gene was FGFR3, an FGF receptor.
FGF9 plays a key role in testis differentiation, and in the
regulation of germ cell development [56–58]. Several
FGF receptors exist in vertebrate species. Loss of FGFR2
in mice testis leads to partial sex reversal [75], but intri-
guingly both FGFR2 and FGFR3 show significant female-
biased expression in our E6 data. FGFR3 has been
shown to interact with FGF1 and FGF9 [76] and is
thought to be important in the post-natal testis [77]. A
role for FGFR3 has not yet been described in the ovary
during embryogenesis. Interestingly, FGF9 itself was very
weakly expressed in E6 gonads, and was not sex-biased,
and so the role of this FGF may not be conserved
outside mammals. (Although a role could be played
by a related FGF). Furthermore, we did not identify
any FGF ligand showing male-biased expression at
E6. In contrast, FGF16 showed robust female-biased
expression. This FGF is also female-biased in Nile
tilapia gonads [78], and may play a role in early
oocyte development. It is interesting to speculate
that FGF16 signalling though FGFR2/3 in the female
may contribute to ovary differentiation or female
germ cell maturation in chickens.
CAPN5 was expressed in the adrenal glands of both
sexes, and the gonads of the female only, where it was
found in a subset of cells present in the juxta-cortical
medulla. The 3βHSD enzyme, which is involved in the
synthesis of sex steroids testosterone and oestrogen is
also expressed in a similar subset of cells as well as the
adrenal glands (Lambeth et al. Submitted). This indi-
cates that different cell lineages exist in the medulla and
it appears that CAPN5 is expressed in a subset of these.
These data suggest that this novel candidate may be
involved in the differentiation or function of steroid pro-
ducing cells in the ovary as well as in the adrenal glands
of both sexes.
In contrast, our third ovarian candidate, GPR56, was
expressed in cortex of the differentiating ovary as it
proliferates during ovarian development. WNT4 and
RSPO1 are expressed in the cortex of the developing
ovary, and their activated transcription factor β-catenin
appears to be stabilized there [5]. Recently, another G-
protein coupled receptor, Lgr5 has been shown to be
expressed in cortical granulosa precursor cells, and plays
a role in germ cell differentiation and survival [79].
Indeed, LGR5 binds R-spondin proteins and enhances
RSPO/WNT/β-catenin signalling [80–83]. It will be in-
teresting to determine if GPR56 also interacts with this
pathway in the cortex of the chicken ovary.
These genes are all interesting candidates for ovarian
development and functional studies including overex-
pression and knockdown are now underway in our la-
boratory to establish their exact roles. Most recently, we
have developed the method of in ovo electroporation to
deliver genes or antisense RNAs directly into developing
gonads [3, 84]. This methodology is being used to
manipulate the novel candidate genes identified in the
current study.
Several caveats to this type of analysis that focuses on
sexually dimorphic genes is that not all key genes in-
volved in ovarian versus testicular development will be
expressed in a sex-biased fashion. Some genes may be
expressed in both sexes but only have a key role on one
sex. In mouse embryos, Gadd45g and Map3k4 are
expressed in the early gonad equally in both sexes, yet
mutations in these genes lead only to sex reversal in XY
males [85–87] because they act on the SRY gene (present
on the Y chromosome) through the p38 MAPK pathway.
Typically these genes have been identified in human
DSD cases or mouse mutants. In addition, this analysis
was based on genes correctly annotated in the Galgal4
chicken genome, thus missing genes that are unanno-
tated or lie in regions that have typically been difficult to
sequence. De novo transcript assembly of the mRNAs
expressed at E6 may reveal additional novel candidates
for sex determination.
Conclusions
This study represents the first RNA-seq analysis of
embryonic gonads at the time of sexual differentiation.
These data have provided a detailed view of the transcrip-
tional changes that occur when sexual differentiation
begins. Over 1000 genes were significantly sexually
DE at this stage, most of which are autosomal genes.
Many of these likely contribute to the morphological
changes taking place, such as ECM remodelling and
tubulogenesis. These data provide several new candi-
date ovary or testis differentiation genes, some of
which we have validated in vivo. In particular, we
show that CAPN5 and GPR56 are excellent candi-
dates for ovarian development. Functional studies on
these novel candidates are now underway in our
laboratory, with a view to clarifying their roles in
gonadal development and differentiation.
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Methods
Embryo incubation and tissue collection
All experimental work adhered to the Australian code of
practice for the care and use of animals for scientific
purposes (7th edition, 2004) and to in-house animal
handling guidelines (Murdoch Childrens Research Insti-
tute and CSIRO Australian Animal Health Laboratory).
Ethics was from MCRI - Chicken Ethics: Institute Animal
Ethics number A627. IBC (Institute Biosafety Committee):
103ext-2007, and 194–2013 EXEMPT. All experiments
were carried out on a single line of Specific Pathogen Free
embryos (SPAFAS) from the White Leghorn strain of
chick (Lohman-LSL) and incubated at 37.8 °C with
rocking in a humidified incubator. For RNA-seq, SPF
eggs were incubated until stage 29 (embryonic day 6)
or E4.5 see [14]. Paired gonads were removed and
stored at −80 °C. Embryos were sexed by PCR as de-
scribed previously [88], briefly, a small piece of limb tissue
was digested in PCR compatible buffer containing protein-
ase K (200 μg/ml at 50 °C for at least 30 min), followed by
rapid PCR amplification of the sex-linked, female-specific
Xho1 sequence. Amplification of 18S ribosomal RNA
genomic sequence was used as the internal control in a
duplex reaction.
RNA extraction and sequencing
Tissues were pooled according to sex. Eighteen paired
gonads (i.e. left and right gonads from 18 individuals)
were pooled for each replicate (two male replicates and
two female replicates). Pooling has been documented as
an appropriate way to prepare samples for expression
analysis [89]. Total RNA was extracted using the RNeasy
micro kit (QIAGEN). On column DNAsing was per-
formed to remove contaminating genomic DNA. The
resulting 4 RNA replicates were poly A-selected, reverse
transcribed, fragmented, bar-coded and sequenced using
the Illumina HiSeq2000 at Australian Genome Research
Facility (AGRF) in Melbourne. We sequenced 100 base
pair, paired ends reads.
Bioinformatic analysis
Differential expression (DE) analysis on the raw reads
was carried out by testing the female read counts against
male read counts using edgeR [90], using count data
from E6 and earlier time-points from [14]. P-values were
adjusted for multiple testing using the Benjamini and
Hochberg false discovery rate (FDR) method [91]. Se-
quenced read pairs (from both E6 and E4.5 time-points)
were mapped to the chicken genome (galGal4) using the
TopHat 2.0.6 software [92]. We used Ensembl version
73, which has 17108 genes. The Ensembl gene annota-
tion was provided to TopHat to aid alignment, with
other settings default. Read pairs were summarized to
Ensembl gene-level counts using featureCounts [93].
Default edgeR settings were used including normalisa-
tion using TMM. Homology of the read-pairs with
Ensembl genes was then calculated, and expression for
each gene calculated in Fragments Per Kilobase Of Exon
Per Million Fragments Mapped (FPKM).
Genes were sorted based on their minimum P-value
(irrespective of time-point) and the top 400 DE genes
were hierarchical clustered. Clustering was performed
on the proportion of counts in each sample with respect
to the sum across samples, after normalising for library
size. The clustering and heatmap were created using the
hclust and heatmap.2 functions in R respectively (using
default settings - agglomeration clustering using complete
linkage). Gene ontology and KEGG pathway analysis were
carried out using DAVID according to the default actions.
Screen comparison
Gene lists (converted to mouse universal gene symbol)
were compiled for each significantly sexually dimorphic
gene (generally P-value <0.05, FC of 1.5 or 2) described
in each study using DAVID software (from either Ensembl
ID, microarray ID or Unigene ID). Gene lists were then
compared using R (version 3.2.0), and one-sided Fisher
exact test was used to obtain a P-value for enrichment.
Embryos for in vivo studies
Fertile eggs (SPF) were obtained from CSIRO, Werribee
and incubated under humid conditions at 37.8 °C. Em-
bryos were harvested at various days throughout devel-
opment and staged according to the morphological
criteria of Hamburger and Hamilton [15]. The UGS
including the mesonephric kidneys, gonads and Müllerian
duct were dissected out in PBS and fixed for either WISH
or immunofluorescence.
Whole-mount in situ hybridisation
Plasmids containing fragments of mRNA for each
gene were ordered from the BBSRC ChickEST Data-
base. These were verified by PCR and sequencing. The
clones were as follows; ZNF385b - ChEST470h3,
BMPR2 - ChEST10191l3, NZP – ChEST203m10,
Laminin - ChEST791a8 CAPN5 – ChEST992n12,
FGFR3 – ChEST779m22. For the GPR56 and the
ZNF385b the ORFs were also used to generate probes in
pGEM T-easy. Probes were made using the either T7, Sp6
or T3 RNA polymerase and labelled with digoxygenin
(DIG). In situ hybridization was performed as described
previously [9, 94]. Briefly, UGS were dissected from em-
bryos and fixed overnight at 4 °C in 4 % paraformalde-
hyde. At least three embryos were used for each sex and
time point or condition. They were then processed for in
situ hybridization with the DIG-labelled antisense ribop-
robe. For negative controls, a DIG-labelled sense ribop-
robe was generated for each gene. Alkaline phosphatase
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conjugated Anti-DIG antibodies were used, and the chro-
magen was BCIP/NBT. Following WISH, specimens were
photographed again under bright field and were then
over-stained before being imbedded in OCT for cryosec-
tioning (sections were cut at 10, 14 and 18 μm). Staining
was analysed by photography under bright field and pho-
tos taken of sections using 5x and 20x lenses. Both sense
and antisense probes were initially tested for all genes.
Staining was only observed with antisense probes, and not
in the sense controls (data not shown).
Immunostaining
Urogenital tissues were dissected from chicken embryos
and briefly fixed for 15 min in 4 % paraformaldehyde/
PBS at room temperature. Tissues were then cryopro-
tected by immersion in 30 % sucrose/PBS (overnight at
4 °C), infiltrated with OCT embedding compound. Ten
micron frozen sections on slides were treated as previ-
ously described [63]. Secondary antibodies were AlexFluor
488 donkey anti-rabbit IgG, 1:1000, and AlexaFluor 594
donkey anti-mouse IgG, at 1:1500 from Invitrogen). Sec-
tions were mounted in Fluorosave (Calbiochem). Images
were taken on a Zeiss Axiovision M1.
Antibodies
Antibodies were raised against the chicken GPR56 and
CAPN5 proteins at GenScript. Two affinity purified poly-
clonal rabbit antibodies were raised for each, against the
peptides VSEPIDLTEGDYTTC or CHLQDRGNRRSNDLP
for CAPN5 and CAFASPKEENREVQG or CWREDGTA
SSGNWDS, for GPR56. The FGFR3 antibody was from
Bioss (bs-0165R) and used at 1:100.
Cell culture
To test the GPR56 antibody in vitro, the GPR56 ORF




GCAGGTGGTAGA. GPR56 was cloned into the Tol2
plasmid under the CMV promoter. Chicken fibroblasts
were transfected according to the Lipofectamine 2000
protocol (Life Technologies) with either empty or
GPR56 Tol2 vector. Anti-GPR56 antibodies 1 and 2
were tested at various concentrations (1 :500, 1: 2000,
1:10,000) and assessed for specific staining using im-
munofluorescence as described above. CAPN5 ORF
was cloned into the RCAS.BP.A avian retroviral vector.
This was transfected into cells, which were passaged at
least once to allow the spread of virus. These cells and
control/uninfected cells were then fixed and stained
with the two antibodies as above. Anti-P27 was used to
check viral infection (not shown).
Availability of supporting data
RNA-seq data for both time points has been uploaded to





Additional file 1: Table S3. Mouse screen comparison using chicken
DE genes (p-value <0.001). Results from one-sided Fisher exact test using
chicken DE genes with p-value 0.001 as a cutoff. (XLSX 34 kb)
Additional file 2: Table S1. Genes used for DAVID analysis of gene
ontology and KEGG pathways. Total genes were filtered for those
showing only DE expression (P-value <0.001) at E6 and not E4.5, to
isolate those genes that become dimorphically expressed as the gonad
begin to differentiate. We removed well-characterized sex genes such as
FOXL2 and SOX9 to allow identification of additionally activated pathways.
This resulted in a list of 774 genes, which were subject to DAVID analysis. In
the table expression (shown as FPKM) is shown for female and males at E4.5
and E6. P-values for the differences between females and males are shown
for each time point (BH_PValue 4.5 or 6). P-values are adjusted using
Benjamini & Hochberg method. (XLSX 193 kb)
Additional file 3: Figure S1. Example of top KEGG pathways showing
sex-biased expression in E6 gonads. DAVID KEGG pathway analysis was
carried out on all genes showing a significant sexually dimorphic expression
(P-value <0.001) at E6, but excluding those at E4.5 and known sex genes
(Additional file 2: Table S1). This revealed several additional pathways that
were significantly represented. (A) Focal adhesion pathway, which was the
most highly represented KEGG pathway in DAVID analysis of all genes. Red
stars indicate those genes that were in our DE list. (B) Pathway for
the regulation of actin cytoskeleton. Red starts indicate genes found
in our list. (TIFF 11721 kb)
Additional file 4: Table S2. Top 45 female and top 45 male biased
genes. For male genes we filtered for sexually dimorphic genes at E6
(p < 0.001) which were male biased (Fem:male ratio of less than 0), with a
male gonadal expression of more than FPKM 10 at E6. These were ranked
according to P-value. We took the top 45 genes. For female genes we
filtered for sexually dimorphic genes at E6 (p < 0.001) which were female
biased (Fem:male ratio of greater than 0), with a female gonadal expression
of more than FPKM 10 at E6. In the table expression (shown as FPKM) is
shown for female and males at E4.5 and E6. P-values for the differences
between females and males are shown for each time point (BH_PValue 4.5 or
6). P-values are adjusted using Benjamini & Hochberg method. (XLSX 68 kb)
Additional file 5: Figure S2. Validation of newly raised antibodies for
chicken GPR56 and CAPN5. Antibodies were tested at various concentrations
(not shown) in chicken DF1 fibroblasts either transfected with a control
plasmid or a plasmid expression protein of choice. (A) Only low background
staining is shown for GPR56 in control cells, whereas when transfected with
GPR56 expressing plasmid staining was observed (B). This staining is mostly
cytoplasmid (see Bi, Bii). (C) Some weak background staining was seen in
control cells, compared to those over-expressing CAPN5 (D). This
staining is punctate and cytoplasmic (Di, Dii), similar to what is seen
in vivo. Additional examples of in vivo staining for GPR56 in male
E8.5 gonads (E) and female (F). (TIFF 11721 kb)
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